{"id":1770,"date":"2026-09-19T22:25:22","date_gmt":"2026-09-19T22:25:22","guid":{"rendered":"https:\/\/simplelifescience.com\/custom-synthesis-specs-to-your-r-d-pipeline-workflow\/"},"modified":"2026-09-19T22:25:22","modified_gmt":"2026-09-19T22:25:22","slug":"custom-synthesis-specs-to-your-r-d-pipeline-workflow","status":"publish","type":"post","link":"https:\/\/simplelifescience.com\/es\/custom-synthesis-specs-to-your-r-d-pipeline-workflow\/","title":{"rendered":"Custom Peptide Synthesis Project Workflow (2026 Guide)"},"content":{"rendered":"<style>.pseo-content { font-size: 17px; line-height: 1.7; color: inherit; }\n.pseo-content h2 { font-size: 1.6em; margin-top: 1.8em; margin-bottom: 0.6em; line-height: 1.3; color: inherit; }\n.pseo-content h3 { font-size: 1.25em; margin-top: 1.5em; margin-bottom: 0.4em; line-height: 1.35; color: inherit; }\n.pseo-content h4 { color: inherit; }\n.pseo-content p { margin: 0 0 1em; }\n.pseo-content ul, .pseo-content ol { margin: 0 0 1em 1.4em; padding: 0; }\n.pseo-content li { margin: 0.3em 0; }\n.pseo-content strong { font-weight: 600; }\n.pseo-content blockquote { margin: 1.2em 0; padding: 0.6em 1em; border-left: 3px solid color-mix(in srgb, currentColor 30%, transparent); background: color-mix(in srgb, currentColor 4%, transparent); color: inherit; }\n.pseo-content a { text-decoration: underline; }<\/p>\n<p>.pseo-content .pseo-table-wrap { overflow-x: auto; margin: 1.4em 0; -webkit-overflow-scrolling: touch; }\n.pseo-content table { width: 100% !important; border-collapse: collapse !important; table-layout: auto !important; font-size: 0.96em; }\n.pseo-content table th,\n.pseo-content table td {\n  padding: 10px 12px !important;\n  border-bottom: 1px solid color-mix(in srgb, currentColor 14%, transparent) !important;\n  border-left: none !important;\n  border-right: none !important;\n  vertical-align: top !important;\n  text-align: left !important;\n  word-break: break-word !important;\n  overflow-wrap: anywhere !important;\n  white-space: normal !important;\n}\n.pseo-content table th {\n  background: color-mix(in srgb, currentColor 6%, transparent) !important;\n  color: inherit !important;\n  font-weight: 600 !important;\n  border-top: 1px solid color-mix(in srgb, currentColor 14%, transparent) !important;\n}\n.pseo-content table tr:last-child td { border-bottom: 1px solid color-mix(in srgb, currentColor 14%, transparent) !important; }<\/style>\n<div class=\"pseo-content\">\n<p>Routing a custom peptide synthesis request through sequence design, feasibility review, synthesis, purification, and analytical release by email and spreadsheet loses specification detail at every handoff. A defined project workflow \u2014 one that carries the written scope from Scientific Brief through procurement, production, and verification into your lab&#39;s own record system \u2014 keeps acceptance criteria, lot numbers, and Certificates of Analysis traceable instead of buried in a thread. This is the custom peptide synthesis project management workflow that qualified laboratory and institutional buyers use to move a request from Define to Document without re-keying data at each stage.<\/p>\n<div class=\"pseo-tldr\" style=\"display:flow-root;clear:both;margin:32px 0;padding:24px 28px;border:1px solid;border-color:rgba(128,128,128,0.35);border-color:color-mix(in srgb, currentColor 14%, transparent);border-left:3px solid;border-left-color:rgba(128,128,128,0.6);border-left-color:color-mix(in srgb, currentColor 30%, transparent);border-radius:12px;background-color:rgba(128,128,128,0.06);background-color:color-mix(in srgb, currentColor 4%, transparent);max-width:100%;\">\n<div class=\"pseo-tldr-label\" style=\"font-size:11px;font-weight:700;letter-spacing:0.12em;text-transform:uppercase;color:rgba(128,128,128,0.9);color:color-mix(in srgb, currentColor 55%, transparent);margin-bottom:12px;\">TL;DR<\/div>\n<ul style=\"float:none;margin:0;padding-left:20px;list-style:disc;\">\n<li style=\"float:none;margin:8px 0;font-size:15px;line-height:1.6;color:inherit;\">A custom peptide synthesis project management workflow moves a request through five stages: Define, Plan, Produce, Verify, Document.<\/li>\n<li style=\"float:none;margin:8px 0;font-size:15px;line-height:1.6;color:inherit;\">Simple Life Science ties each Scientific Brief to a written scope with fixed acceptance criteria before quoting starts.<\/li>\n<li style=\"float:none;margin:8px 0;font-size:15px;line-height:1.6;color:inherit;\">Amend the written scope before synthesis begins \u2014 changes made mid-Produce restart the Verify stage.<\/li>\n<li style=\"float:none;margin:8px 0;font-size:15px;line-height:1.6;color:inherit;\">The same workflow shortens for recurring bulk API reorders, skipping feasibility review when the specification is already validated.<\/li>\n<li style=\"float:none;margin:8px 0;font-size:15px;line-height:1.6;color:inherit;\">Lot records land in your ELN or LIMS as documentation, not as a manual re-entry task.<\/li>\n<\/ul>\n<\/div>\n<h2>Why this matters<\/h2>\n<p>A custom synthesis order that skips a documented workflow tends to fail at the point where a specification detail \u2014 a purity threshold, an analytical method, a delivery format \u2014 gets restated verbally instead of written down. That gap shows up later as a Certificate of Analysis that doesn&#39;t match what the requesting scientist expected, and a project that stalls while the mismatch gets resolved.<\/p>\n<p>Procurement teams managing multiple concurrent synthesis requests feel this most. The <a href=\"https:\/\/simplelifescience.com\/peptide-sourcing-for-procurement-teams-complete-guide\/\">peptide sourcing for procurement teams<\/a> process depends on the same discipline this workflow enforces: a written scope fixed before a purchase order is cut, not negotiated after synthesis is underway. In 2026, labs running multiple simultaneous custom synthesis projects need this control point more than they need faster turnaround.<\/p>\n<h2>Before you start<\/h2>\n<ul>\n<li><strong>A completed Scientific Brief<\/strong> \u2014 target sequence, required purity specification, quantity, analytical method, and delivery format defined in writing.<\/li>\n<li><strong>Procurement authorization<\/strong> \u2014 a purchase order number, or a punchout catalog connection if your institution routes orders that way.<\/li>\n<li><strong>A destination for lot records<\/strong> \u2014 ELN or LIMS credentials for the system your research team will query later.<\/li>\n<\/ul>\n<p>The gotcha: acceptance criteria \u2014 purity threshold, mass confirmation method, endotoxin limit if relevant to the application \u2014 must be fixed <em>before<\/em> a quotation is generated. Criteria added after synthesis starts require a written scope amendment, and that amendment restarts the Verify stage. Fix this at Define, not at Verify.<\/p>\n<h2>Define the Scientific Brief<\/h2>\n<p>The Scientific Brief is the single document every downstream stage references. Incomplete fields here are the most common cause of a stalled feasibility review.<\/p>\n<ol>\n<li>Enter the <strong>Target Sequence<\/strong> field with the exact sequence and any modification (acetylation, amidation, cyclization) written out in full \u2014 not abbreviated shorthand your synthesis partner has to interpret.<\/li>\n<li>Set the <strong>Purity Specification<\/strong> field as a numeric threshold (for example, greater than or equal to 95% by HPLC), not a qualitative description like &quot;high purity.&quot;<\/li>\n<li>Specify the <strong>Analytical Method<\/strong> field \u2014 HPLC, LC-MS, or both \u2014 since a reportable purity value changes depending on which method generates it.<\/li>\n<li>Complete <strong>Quantity Required<\/strong> and <strong>Delivery Format<\/strong> (lyophilized powder, specific vial size, custom packaging) so the Produce stage has a fixed target.<\/li>\n<\/ol>\n<p><strong>Expected result:<\/strong> a written scope document with acceptance criteria fixed before a quotation goes out, not negotiated afterward.<\/p>\n<h2>Route the Request Through Procurement<\/h2>\n<p>Once the Scientific Brief is complete, the request has to clear procurement before synthesis starts.<\/p>\n<ol>\n<li>If your institution routes laboratory purchases through a punchout catalog, <a href=\"https:\/\/simplelifescience.com\/how-to-connect-simple-life-science-to-your-punchout-catalog\/\">connect Simple Life Science to your punchout catalog<\/a> before submitting the brief so the order lands with the right cost center automatically.<\/li>\n<li>If your institution issues a direct purchase order instead, attach the PO number to the Scientific Brief submission.<\/li>\n<li>Confirm the authorized quantity on the PO matches the Quantity Required field from the brief \u2014 mismatches here are the second most common cause of delayed feasibility review.<\/li>\n<\/ol>\n<p><strong>Expected result:<\/strong> the Scientific Brief and its procurement authorization are matched before the Plan stage opens, so synthesis isn&#39;t blocked mid-project waiting on a corrected PO.<\/p>\n<h2>Track Synthesis and Verification Stages<\/h2>\n<p>This is where the written scope becomes a physical lot.<\/p>\n<ol>\n<li><strong>Feasibility Review<\/strong> \u2014 synthesis chemistry confirms the sequence and modification are producible at the specified purity and scale before Produce begins.<\/li>\n<li><strong>Produce<\/strong> \u2014 synthesis and purification run against the written scope, not against a verbal restatement of it.<\/li>\n<li><strong>Verify<\/strong> \u2014 analytical characterization (HPLC, mass spectrometry, or both, matching the method fixed at Define) tests the lot against the acceptance criteria set in the Scientific Brief.<\/li>\n<li>A <strong>Certificate of Analysis<\/strong> is issued per lot, reporting the result against the exact criteria the brief specified \u2014 not a generic purity claim.<\/li>\n<\/ol>\n<p><strong>Expected result:<\/strong> the Certificate of Analysis matches the acceptance criteria defined at the start of the project. Any exception is flagged before the lot is released, not after it ships.<\/p>\n<figure class=\"pseo-image\" style=\"display:flow-root;clear:both;margin:32px 0;padding:0;max-width:100%;\"><img decoding=\"async\" src=\"https:\/\/gwvckixiegkllthleuyt.supabase.co\/storage\/v1\/object\/public\/workspace-article-images-public\/7b29229a-4b54-4da7-89ee-7b5c1ac819f1\/body-b077646b7385340b76f36d205e096cc2.jpg\" alt=\"Vertical timeline showing the Define, Plan, Produce, Verify, Document stages of a custom peptide synthesis project\" loading=\"lazy\" style=\"display:block;float:none;width:100%;height:auto;max-width:100%;border-radius:12px;margin:0;\"\/><figcaption style=\"margin:10px 0 0;font-size:13px;line-height:1.5;text-align:center;color:rgba(128,128,128,0.85);color:color-mix(in srgb, currentColor 58%, transparent);\">Each stage produces a record the next stage depends on \u2014 skipping documentation at one stage stalls the next.<\/figcaption><\/figure>\n<h2>Land Lot Records in Your ELN or LIMS<\/h2>\n<p>A Certificate of Analysis that lives only in an email inbox isn&#39;t queryable by the rest of the research team.<\/p>\n<ol>\n<li>Request the lot-level documentation package at the time of shipment \u2014 this is the same package described in the <a href=\"https:\/\/simplelifescience.com\/certificates-of-analysis-to-eln-ready-records-workflow\/\">certificates of analysis to ELN-ready records<\/a> workflow.<\/li>\n<li>Map the fields your ELN or LIMS expects \u2014 lot number, synthesis date, purity result, storage condition \u2014 against the fields the documentation package provides.<\/li>\n<li>Confirm the record is accessible to every researcher who will reference that lot, not just the person who placed the order.<\/li>\n<\/ol>\n<p><strong>Expected result:<\/strong> the lot record is queryable inside your ELN or LIMS without manual re-entry, and it stays attached to every future reference to that lot.<\/p>\n<h2>Track a Bulk API Reorder Instead of a New Synthesis<\/h2>\n<p>The workflow shortens for a recurring bulk peptide API order against a specification that&#39;s already been validated. <strong>Skip Feasibility Review<\/strong> \u2014 the sequence and purity threshold are already proven \u2014 and route the request straight to Produce and Verify against the prior written scope.<\/p>\n<p>The difference that matters here is provenance: a reorder should inherit the documentation trail of the original lot, not start a fresh one. The <a href=\"https:\/\/simplelifescience.com\/peptide-orders-to-freezer-ready-lot-traceability-workflow\/\">peptide orders to freezer-ready lot traceability<\/a> workflow covers how a repeat order carries forward storage condition and chain-of-custody records instead of generating a disconnected new file. <strong>Reorders that skip this step lose the link between the new lot and the original validated specification \u2014 verify the link before accepting the shipment, not after.<\/strong><\/p>\n<div class=\"pseo-quote\" style=\"display:flow-root;clear:both;margin:32px 0;padding:24px 28px;border-left:3px solid;border-left-color:rgba(128,128,128,0.6);border-left-color:color-mix(in srgb, currentColor 30%, transparent);border-radius:12px;background-color:rgba(128,128,128,0.06);background-color:color-mix(in srgb, currentColor 4%, transparent);max-width:100%;\">\n<p style=\"margin:0;font-size:19px;font-weight:500;font-style:normal;line-height:1.5;color:inherit;\">\u201cAcceptance criteria defined before quoting is the single control point that prevents a stalled Verify stage.\u201d<\/p>\n<\/div>\n<div class=\"pseo-cta\" style=\"display:flow-root;clear:both;margin:32px 0;padding:28px;border:1px solid;border-color:rgba(128,128,128,0.35);border-color:color-mix(in srgb, currentColor 14%, transparent);border-radius:12px;background-color:rgba(128,128,128,0.06);background-color:color-mix(in srgb, currentColor 4%, transparent);max-width:100%;text-align:center;\">\n<p style=\"margin:0;font-size:20px;font-weight:700;line-height:1.35;letter-spacing:-0.01em;color:inherit;\">Submit a scientific brief<\/p>\n<p style=\"margin:8px 0 0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">Request a quotation scoped to a defined specification and acceptance criteria.<\/p>\n<div style=\"display:flex;flex-wrap:wrap;justify-content:center;gap:10px;margin-top:18px;\"><a class=\"pseo-cta-button\" href=\"https:\/\/simplelifescience.com\/\" style=\"display:inline-block;padding:14px 28px;border:1px solid;border-color:rgba(128,128,128,0.9);border-color:color-mix(in srgb, currentColor 55%, transparent);border-radius:10px;background-color:rgba(128,128,128,0.12);background-color:color-mix(in srgb, currentColor 10%, transparent);font-size:16px;font-weight:700;line-height:1.4;color:inherit;text-decoration:none;\">Start a project<\/a><\/div>\n<\/div>\n<h2>Troubleshooting<\/h2>\n<ul>\n<li><strong>Quotation is taking longer than expected.<\/strong> Check the Scientific Brief for a missing acceptance criteria field \u2014 an incomplete purity or analytical method field is the most common cause of a stalled feasibility review.<\/li>\n<li><strong>The Certificate of Analysis reports a different purity value than expected.<\/strong> Confirm the analytical method on the CoA matches what the written scope specified. HPLC and LC-MS report different values for the same lot, and a mismatch here is a method discrepancy, not a synthesis defect.<\/li>\n<li><strong>The lot record isn&#39;t appearing in your LIMS.<\/strong> Confirm field mapping was completed when the documentation package was first requested, then re-request the package rather than re-entering the data manually.<\/li>\n<li><strong>A punchout catalog connection fails at submission.<\/strong> Verify the catalog connection was completed correctly before the Scientific Brief is submitted \u2014 a broken connection routes the order to the wrong cost center instead of rejecting it outright.<\/li>\n<li><strong>A reorder&#39;s specification appears to have drifted from the original lot.<\/strong> Request a side-by-side comparison against the original Certificate of Analysis before accepting the new lot into inventory.<\/li>\n<\/ul>\n<h2>Customize your workflow<\/h2>\n<p>The five-stage structure holds for a single custom synthesis order and for a recurring bulk API contract, but the documentation depth should scale with who&#39;s downstream. A university lab tracking one sequence for a single study needs less than an institutional buyer running the same specification across multiple sites. Review the <a href=\"https:\/\/simplelifescience.com\/peptide-sourcing-for-procurement-teams-complete-guide\/\">peptide sourcing for procurement teams<\/a> process again once your first project clears Document \u2014 the second and third orders move faster once the punchout connection and ELN mapping are already in place from the first one.<\/p>\n<p>Heading into 2026, the labs getting the most out of this workflow are the ones that write the acceptance criteria into the Scientific Brief in numeric terms the first time, not the ones with the fastest synthesis turnaround.<\/p>\n<h2>FAQ<\/h2>\n<div class=\"pseo-faq\" style=\"display:flow-root;clear:both;margin:32px 0;padding:8px 28px;border:1px solid;border-color:rgba(128,128,128,0.35);border-color:color-mix(in srgb, currentColor 14%, transparent);border-radius:12px;background-color:rgba(128,128,128,0.06);background-color:color-mix(in srgb, currentColor 4%, transparent);max-width:100%;\">\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">What is a custom peptide synthesis project management workflow?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">It&#8217;s a defined sequence of stages \u2014 Define, Plan, Produce, Verify, Document \u2014 that carries a written scope and acceptance criteria from initial request through to a lot record in your ELN or LIMS. It replaces email-based tracking with a document trail every stage can reference.<\/p>\n<\/div>\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;border-top:1px solid;border-top-color:rgba(128,128,128,0.35);border-top-color:color-mix(in srgb, currentColor 14%, transparent);\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">What has to be in a Scientific Brief before requesting a quote?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">A complete brief includes the target sequence, any modification, a numeric purity specification, the analytical method (HPLC, LC-MS, or both), required quantity, and delivery format. Missing acceptance criteria fields are the most common cause of a delayed feasibility review.<\/p>\n<\/div>\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;border-top:1px solid;border-top-color:rgba(128,128,128,0.35);border-top-color:color-mix(in srgb, currentColor 14%, transparent);\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">Can acceptance criteria be changed after synthesis starts?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">Yes, but it requires a written scope amendment and restarts the Verify stage for that lot. Fixing criteria at the Define stage avoids this delay entirely.<\/p>\n<\/div>\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;border-top:1px solid;border-top-color:rgba(128,128,128,0.35);border-top-color:color-mix(in srgb, currentColor 14%, transparent);\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">How does a bulk API reorder differ from a new custom synthesis project?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">A reorder against a previously validated specification skips Feasibility Review and routes straight to Produce and Verify, inheriting the documentation trail of the original lot instead of starting a new one.<\/p>\n<\/div>\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;border-top:1px solid;border-top-color:rgba(128,128,128,0.35);border-top-color:color-mix(in srgb, currentColor 14%, transparent);\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">Why does a Certificate of Analysis sometimes report a different purity value than expected?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">Purity values differ by analytical method \u2014 HPLC and LC-MS report different numbers for the same lot. Confirm the CoA method matches the method specified in the written scope before treating a discrepancy as a synthesis issue.<\/p>\n<\/div>\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;border-top:1px solid;border-top-color:rgba(128,128,128,0.35);border-top-color:color-mix(in srgb, currentColor 14%, transparent);\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">How do lot records get into an ELN or LIMS without manual entry?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">The documentation package requested at shipment maps directly to standard ELN and LIMS fields \u2014 lot number, synthesis date, purity result, storage condition \u2014 so the record loads without re-keying.<\/p>\n<\/div>\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;border-top:1px solid;border-top-color:rgba(128,128,128,0.35);border-top-color:color-mix(in srgb, currentColor 14%, transparent);\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">Does a punchout catalog connection change how the Scientific Brief is submitted?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">No \u2014 the brief is submitted the same way. The punchout connection routes the resulting purchase order to the correct cost center automatically instead of requiring a manually entered PO number.<\/p>\n<\/div>\n<div class=\"pseo-faq-item\" style=\"padding:16px 0;border-top:1px solid;border-top-color:rgba(128,128,128,0.35);border-top-color:color-mix(in srgb, currentColor 14%, transparent);\">\n<p style=\"margin:0 0 6px;font-size:16px;font-weight:700;color:inherit;\">What causes a custom synthesis project to stall between stages?<\/p>\n<p style=\"margin:0;font-size:15px;line-height:1.6;color:rgba(128,128,128,0.95);color:color-mix(in srgb, currentColor 78%, transparent);\">Most stalls trace back to an incomplete Scientific Brief, a mismatched purchase order quantity, or acceptance criteria added after synthesis has already started. All three are avoidable at the Define stage.<\/p>\n<\/div>\n<\/div>\n<h2>One last thing<\/h2>\n<p>The acceptance criteria written into the Scientific Brief become the exact specification tested at Verify \u2014 vague language at Define costs more project time in 2026 than any step in the synthesis chemistry itself. A numeric purity threshold and a named analytical method, fixed before the quote goes out, is the cheapest control point in the entire custom peptide synthesis project management workflow.<\/p>\n<h2>Related guides<\/h2>\n<ul>\n<li><a href=\"https:\/\/simplelifescience.com\/peptide-orders-to-freezer-ready-lot-traceability-workflow\/\">Peptide orders to freezer-ready lot traceability workflow<\/a><\/li>\n<li><a href=\"https:\/\/blog.simplelifescience.com\/best-custom-peptide-synthesis-companies-for-biotech-startups\">Best custom peptide synthesis companies for biotech startups<\/a><\/li>\n<\/ul>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is a custom peptide synthesis project management workflow?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It's a defined sequence of stages \u2014 Define, Plan, Produce, Verify, Document \u2014 that carries a written scope and acceptance criteria from initial request through to a lot record in your ELN or LIMS. It replaces email-based tracking with a document trail every stage can reference.\"}},{\"@type\":\"Question\",\"name\":\"What has to be in a Scientific Brief before requesting a quote?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"A complete brief includes the target sequence, any modification, a numeric purity specification, the analytical method (HPLC, LC-MS, or both), required quantity, and delivery format. Missing acceptance criteria fields are the most common cause of a delayed feasibility review.\"}},{\"@type\":\"Question\",\"name\":\"Can acceptance criteria be changed after synthesis starts?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, but it requires a written scope amendment and restarts the Verify stage for that lot. Fixing criteria at the Define stage avoids this delay entirely.\"}},{\"@type\":\"Question\",\"name\":\"How does a bulk API reorder differ from a new custom synthesis project?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"A reorder against a previously validated specification skips Feasibility Review and routes straight to Produce and Verify, inheriting the documentation trail of the original lot instead of starting a new one.\"}},{\"@type\":\"Question\",\"name\":\"Why does a Certificate of Analysis sometimes report a different purity value than expected?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Purity values differ by analytical method \u2014 HPLC and LC-MS report different numbers for the same lot. Confirm the CoA method matches the method specified in the written scope before treating a discrepancy as a synthesis issue.\"}},{\"@type\":\"Question\",\"name\":\"How do lot records get into an ELN or LIMS without manual entry?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The documentation package requested at shipment maps directly to standard ELN and LIMS fields \u2014 lot number, synthesis date, purity result, storage condition \u2014 so the record loads without re-keying.\"}},{\"@type\":\"Question\",\"name\":\"Does a punchout catalog connection change how the Scientific Brief is submitted?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No \u2014 the brief is submitted the same way. The punchout connection routes the resulting purchase order to the correct cost center automatically instead of requiring a manually entered PO number.\"}},{\"@type\":\"Question\",\"name\":\"What causes a custom synthesis project to stall between stages?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Most stalls trace back to an incomplete Scientific Brief, a mismatched purchase order quantity, or acceptance criteria added after synthesis has already started. All three are avoidable at the Define stage.\"}}]}<\/script>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Route custom peptide synthesis specs from Scientific Brief to ELN-ready lot records in 2026 with a Define-to-Document project management workflow.<\/p>","protected":false},"author":2,"featured_media":1769,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":""},"categories":[79],"tags":[],"class_list":["post-1770","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-quality-documentation"],"_links":{"self":[{"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/posts\/1770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/comments?post=1770"}],"version-history":[{"count":0,"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/posts\/1770\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/media\/1769"}],"wp:attachment":[{"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/media?parent=1770"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/categories?post=1770"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/simplelifescience.com\/es\/wp-json\/wp\/v2\/tags?post=1770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}